Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Invesco Ltd: Form 8.3 - American Axle & Manufacturing Holdings Inc; Public dealing disclosure
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 28 02 2025] - (CGWL)
-
Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025
-
Volatus Aerospace and Draganfly Expand Collaboration to Service High-Value Geospatial Power Utility Customers
-
Invitation to HMS Networks’ Capital Markets Day on September 9, 2025
-
ProVen Growth and Income VCT plc: Total voting rights
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
The Joint Corp. to Participate in the 37th Annual Roth Conference
-
ProVen VCT plc: Total voting rights
-
Politecnico di Torino flies to Ethiopia for an institutional mission
-
Abcourt Announces Strategic Partnership With Groupe Minier Technica
-
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results
-
Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
ROME Therapeutics Announces Publication in Nature Communications of First Large-Scale, Pan-Cancer Analysis of LINE-1 Expression Levels and Retrotransposon Activity
-
Emerita Announces Commencement of Hearings to Resolve Corruption Charges Related to Awarding of Aznalcollar Public Tender, Spain
-
Ryman Hospitality Properties, Inc. Provides Investor Presentation Ahead of Upcoming Institutional Investor Conferences
-
Lexicon Pharmaceuticals Announces Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain
-
Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach
-
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urolo
-
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results
-
ArriVent BioPharma Reports Full Year 2024 Financial Results
-
Opthea Announces Phase 2b Wet AMD Publication
-
ScottsMiracle-Gro to Webcast Presentation at Raymond James & Associates 46th Annual Institutional Investors Conference on March 4
-
Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights
-
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
Giyani Produces First Battery-Grade Manganese at its Demo Plant
-
Ligand to Participate in March Investor Conferences
-
BioXcel Therapeutics Announces FDA Closed its Inspection of Site for Phase 3 TRANQUILITY II Trial for Acute Treatment of Agitation Associated with Alzheimer’s Dementia
-
Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease
-
United Lithium Applies to Extend Warrant Expiry Date
-
NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan
-
CareCloud Reignites Acquisition Strategy with MesaBilling Acquisition
-
Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
-
Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development
-
OROCO CLOSES NON-BROKERED PRIVATE PLACEMENT
-
Bitfarms Provides February 2025 Production and Operations Update
-
Falco Receives Additional Comments and Questions From the Ministry of the Environment on the Horne 5 Project
-
Rubicon Organics to Acquire Cultivation Facility in BC to Strengthen Leadership in Premium Cannabis
-
Interpublic Group Announces Sale of R/GA to Truelink Capital
-
Uphold Relaunches Staking Rewards to Customers in the US
-
Conavi Medical Reports Fiscal Q1 2025 Interim Financial Results and Operational Highlights
-
Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-05 in Alzheimer’s Disease Agitation Supporting NDA Submission
-
ABB to invest $120 million to expand US manufacturing
-
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025
-
Next Hydrogen Solutions Inc. Announces Changes to its Board of Directors
-
PolyPid to Participate in the 37th Annual ROTH Conference
-
Montauk Renewables Schedules Full Year 2024 Conference Call for Thursday, March 13, 2025, at 8:30 a.m. ET
-
Technical Requirements for Titanium Coarse Metal Powder Have Been Met by PyroGenesis’ NexGen™ Plasma Atomized Metal Powder for Global Aerospace OEM
-
ScottsMiracle-Gro to Webcast Presentation at Raymond James & Associates 46th Annual Institutional Investors Conference on March 4
